EMCDDA Home
Search

Country overview: Luxembourg

Key statistics on the drug situation in Luxembourg

  Indicator Year (0)   Country
data
EU range  
Min. Max.
Lifetime prevalence of drug use among young adults (15 to 34 years old) cannabis GPS       2.9 % 48 % 1
Lifetime prevalence of drug use among all adults (15 to 64 years old) cannabis       1.5 % 38.6 % 1
Last year prevalence of drug use among young adults (15 to 34 years old) cannabis       0.9 % 20.9 % 1
Last year prevalence of drug use among all adults (15 to 64 years old) cannabis       0.4 % 14.6 % 1
Lifetime prevalence of drug use among young adults (15 to 34 years old) cocaine       0.1 % 12 % 1
Lifetime prevalence of drug use among all adults (15 to 64 years old) cocaine       0.1 % 8.3 % 1
Last year prevalence of drug use among young adults (15 to 34 years old) cocaine       0.1 % 5.5 % 1
Last year prevalence of drug use among all adults (15 to 64 years old) cocaine       0 % 3.1 % 1
Recent school surveys: lifetime prevalence (15 to 16 years old) cannabis EYE       4 % 45 % 2
Recent school surveys: lifetime prevalence (15 to 16 years old) cocaine       1 % 5 % 2
Problem drug use rate per 1 000 population aged 15 to 64 years old PDU       0 9.9 3
Injecting drug use rate per 1 000 population aged 15 to 64 years old       0.6 15.1 3
Infectious diseases (% infected) HIV INF 2007   3.5 % 0 % 39.7 % 3
Infectious diseases (cases per million) HIV infections newly diagnosed in injecting drug users 2007   14.7 0 85.7 2
Infectious diseases (% infected) HCV 2005   71.8–90.7 % 17.9 % 90.7 % 4
Infectious diseases (% infected) HBV HBsAg 2005   3.9 % 0.4 % 7.8 % 4
Drug-related deaths DRD 2007   27 7 2 025 4
Drug law offences (as number of reports of offences) DLO 2007
1 372 878 278 797 5
Drug law offences for use/possession 2006 a 66 66 253 559 4
Cannabis drug law offences i 2006 b 33 % 21 % 82.8 % 5
Number of new clients entering treatment TDI 2007 c 34 34 47 165 6
Number of new clients entering treatment with known primary drug

2007

c 0 0 45 166 6
New clients entering treatment (% opioids of clients with known primary drug)       3.5 % 95 % 6
New clients entering treatment (% cocaine of clients with known primary drug)       0 % 60.3 % 6
New clients entering treatment (% cannabis of clients with known primary drug)       1.6 % 77.9 % 6
Number of all clients entering treatment 2007   376 376 128 208 6
Number of all clients entering treatment with known primary drug 2007   373 0 122 163 6
All clients entering treatment (% opioids of clients with known primary drug) 2007   76.9 % 10.5 % 97.8 % 6
All clients entering treatment (% cocaine of clients with known primary drug) 2007   11.8 % 0.2 % 45.1 % 6
All clients entering treatment (% cannabis of clients with known primary drug) 2007   5.6 % 0.6 % 68.2 % 6
Syringes provided through needle and syringe programmes HSR 2007   287 347 0 4 800 000 4
Number of all clients in substitution treatment 2007
1 092 0 131 468 5
Price in euros per gram cannabis herb ii PPP 2007 d EUR 8 EUR 1 EUR 10 2
Price in euros per gram cannabis resin ii 2007 d EUR 7.50 EUR 4 EUR 13 2
Price in euros per gram cocaine ii 2007 e EUR 30–100 EUR 49 EUR 120 2
Price in euros per gram heroin (brown) ii;iv 2007 e EUR 50–90 EUR 30 EUR 125 2
Price in euros 1 tablet XTC ii 2007 d EUR 5 EUR 3 EUR 15.60 2
Price in euros per gram amphetamine ii 2007 d EUR 5 EUR 9 EUR 37.50 2
Purity (%) cocaine iii 2007   34.4 % 10 % 72 % 2
Purity (%) heroin (brown) iii 2007   10.6 % 2 % 54 % 2
Potency (%) cannabis resin iii;v 2007   2.2 % 2 % 9.1 % 2
Potency (%) cannabis herb iii 2007   9.8 % 0.4 % 9.8 % 2

Notes

i As percentage of all drug law offences.

ii When available, country provides minimum, maximum, average and typical (modal) price in euros. This table shows the typical (modal) price in euros.

iii When available, country provides minimum, maximum, average and typical (modal) purity/potency (percentage). This table shows the typical (modal) purity/potency (percentage).

iv The minimum value in the European range refers to an average price.

v The maximum value in the European range refers to an average potency.

0 Most recent available data shown. Any data prior to 2003 not shown.

1 2003 to 2008 data.

2 2007 data.

3 2003 to 2007 data.

4 2005 to 2007 data.

5 2006 to 2007 data.

6 2007 data excluding Belgium (2005), Spain, Poland and Malta (2006).

a Calculated on arrests for presumed offences against the 1973 drug law.

b Based on number of mentions of cannabis among all drug mentions, whether alone or with other drugs. Calculated on arrests for presumed offences against the 1973 drug law.

c Data on first treatments (breakdown by primary) were not reported for 2007 as the figures were too small.

d Data is the average and not the mode.

e Values are minimum price recorded and maximum price recorded and not the mode.